BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10972678)

  • 1. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef.
    Kajiyama W; Kopp JB; Marinos NJ; Klotman PE; Dickie P
    Kidney Int; 2000 Sep; 58(3):1148-59. PubMed ID: 10972678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.
    Zhong J; Zuo Y; Ma J; Fogo AB; Jolicoeur P; Ichikawa I; Matsusaka T
    Kidney Int; 2005 Sep; 68(3):1048-60. PubMed ID: 16105035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy.
    Dickie P; Roberts A; Uwiera R; Witmer J; Sharma K; Kopp JB
    Virology; 2004 Apr; 322(1):69-81. PubMed ID: 15063118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
    Zuo Y; Matsusaka T; Zhong J; Ma J; Ma LJ; Hanna Z; Jolicoeur P; Fogo AB; Ichikawa I
    J Am Soc Nephrol; 2006 Oct; 17(10):2832-43. PubMed ID: 16988066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice.
    Dickie P
    AIDS Res Hum Retroviruses; 2000 May; 16(8):777-90. PubMed ID: 10826484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV type 1 Nef perturbs eye lens development in transgenic mice.
    Dickie P
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):177-89. PubMed ID: 8835194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of HIV-associated nephropathy.
    Lu TC; He JC; Klotman P
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):233-7. PubMed ID: 16609288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role for Nef in HIV-1-induced podocyte dedifferentiation.
    Sunamoto M; Husain M; He JC; Schwartz EJ; Klotman PE
    Kidney Int; 2003 Nov; 64(5):1695-701. PubMed ID: 14531802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice.
    Singhal PC; Sharma P; Loona R; Gibbons N; Franki N; Klotman PE
    J Investig Med; 1998 Aug; 46(6):297-302. PubMed ID: 9737092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.
    Kopp JB; Klotman ME; Adler SH; Bruggeman LA; Dickie P; Marinos NJ; Eckhaus M; Bryant JL; Notkins AL; Klotman PE
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1577-81. PubMed ID: 1542649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy.
    Barisoni L; Bruggeman LA; Mundel P; D'Agati VD; Klotman PE
    Kidney Int; 2000 Jul; 58(1):173-81. PubMed ID: 10886562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy.
    Ray PE; Liu XH; Robinson LR; Reid W; Xu L; Owens JW; Jones OD; Denaro F; Davis HG; Bryant JL
    Kidney Int; 2003 Jun; 63(6):2242-53. PubMed ID: 12753314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
    Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
    J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on HIV-associated nephropathy.
    Shah SN; He CJ; Klotman P
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):450-5. PubMed ID: 16775461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T lymphocytes in renal disease in HIV-transgenic mice.
    Shrivastav S; Cusumano A; Kanno Y; Chen G; Bryant JL; Kopp JB
    Am J Kidney Dis; 2000 Mar; 35(3):408-17. PubMed ID: 10692266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
    Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
    Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
    Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus downregulates podocyte apoE expression.
    Arora S; Husain M; Kumar D; Patni H; Pathak S; Mehrotra D; Reddy VK; Reddy LR; Salhan D; Yadav A; Mathieson PW; Saleem MA; Chander PN; Singhal PC
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F653-61. PubMed ID: 19553347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.